May Kin Ho

May Kin Ho is currently Director at PAREXEL International Corp.
since 2018, Independent Director at BioMarin Pharmaceutical, Inc. since 2021, Independent Director at Agios Pharmaceuticals, Inc. since 2015, Independent Director at Kyntra Bio, Inc. since 2018, Director at The Aaron Diamond AIDS Research Center since 2005, Director at Pelage Pharmaceuticals, Inc., Director at Parexel International Corp.
Ltd. since 2018, Director at Institute For Protein Innovation, Inc. since 2016, Independent Director at Neumora Therapeutics, Inc. since 2021, Venture Partner at Qiming Venture Partners Ltd., and Managing Partner at Viridian Global Logistics, Inc. Former roles include Independent Director at PAREXEL International Corp.
from 2015 to 2017, Independent Director at GRAIL, Inc. from 2019 to 2021, Director-Strategic Planning, Marketing & Research at DuPont Merck Pharmaceutical Co., Director-Strategic Planning, Marketing & Research at Dupont De Nemours & Co., Inc., Partner & Co-Head-Healthcare at The Goldman Sachs Group, Inc. from 2010 to 2015, and Research Analyst at Goldman Sachs & Co. LLC from 1992 to 2013.
Education includes a doctorate conferred in 1980 and an undergraduate degree conferred in 1975, both from State University of New York at Downstate Medical Center.